Last reviewed · How we verify

NCT04143334

Prevalence of Blindness, Visual Impairment in Chao Nan Area, China

Completed Last updated 31 October 2019
What this trial tests

trial testing Conventional survey in Blindness in 3,700 participants. Completed in 1 December 2016.

Timeline
1 April 2012
Primary endpoint
1 December 2015
1 December 2016

Quick facts

Lead sponsorChinese University of Hong Kong
StatusCompleted
Study typeOBSERVATIONAL
Enrollment3,700
Start date1 April 2012
Primary completion1 December 2015
Estimated completion1 December 2016

Drugs / interventions tested

Conditions studied

Sponsor

Chinese University of Hong Kong

Who can join

50 and older, any sex, with Blindness or Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will provide a profile of blindness/visual impairment, avoidable blindness and cataract surgery service in Chaonan, mainland China. We also evaluate the diagnostic accuracy of Rapid Assessment of Avoidable Blindness (RAAB) comparison with conventional survey.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Blindness

Currently open trials in the same condition.

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04143334.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing